The Global Human Recombinant Insulin Market Propelled By Growing...

adicionou um novo artigo Outro

2023-12-18 10:08:53 -

The Global Human Recombinant Insulin Market Propelled By Growing Prevalence Of Diabetes

Human recombinant insulin is used for the treatment of diabetes. It regulates blood sugar levels by facilitating the passage of glucose from the bloodstream into cells to be used as energy. The rising cases of diabetes globally have fuelled the demand for insulin significantly. The global human recombinant insulin market is estimated to be valued at US$ 41,602.7 Mn in 2023 and is expected to...

0 Comentários 0 Compartilhamentos 924 Visualizações 0 Anterior